Rentokil Initial plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc covers the month of March 2026, with a specific reporting date of March 10, 2026. The document serves as a notification of a transaction by a Person Closely Associated (PCA) with a Person Discharging Managerial Responsibilities (PDMR) under Article 19 of the UK Market Abuse Regulation.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to a specific share transaction:
- Transaction Type: Purchase of American Depositary Shares (ADS).
- Volume: 3,225 ADS.
- Price per ADS: USD $30.9598.
- Total Transaction Value: USD $99,845.36.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document solely discloses an insider-related transaction involving the purchase of company securities.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a regulatory disclosure of a specific share purchase event.
Key Facts for Investor Verification
- Transaction Date: March 9, 2026.
- Buyer Identity: The Samuel J. Mitchell, Jr. Revocable Trust (PCA of Samuel Mitchell, Non-Executive Director).
- Exchange: New York Stock Exchange.
- Instrument: Rentokil Initial plc American Depositary Shares (CUSIP: 760125104).
- Share Conversion: Each ADS represents five ordinary shares of one pence each.